NASDAQ:SKIN
SkinHealth Systems Inc.
SkinHealth Systems Inc.'s revenue fell 10.0% in fiscal 2025 to $300.8M while operating margin rose to −6.9%. Free cash flow was $37.2M, 12.4% of revenue, and the diluted share count fell 4.7%.Summary generated from SkinHealth Systems Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$300.8M
Revenue growth−10.0%
Revenue, 5-yr CAGR+20.4%
Gross margin65.3%
Operating margin−6.9%
Net margin−3.2%
ROICn/a
Return on equity−16.9%
Debt / equityn/a
Free cash flow$37.2M
FCF margin12.4%
Share count change−4.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 260 | 366 | 398 | 334 | 301 |
| Operating income | −40 | −26 | −131 | −68 | −21 |
| Net income | −379 | 44 | −100 | −29 | −10 |
| Free cash flow | −40 | −117 | 18 | 15 | 37 |
Recent filings
- 8-KTermination of a material agreement
Oct 6, 2026 - 8-KResults of a shareholder vote
Sep 28, 2026 - 8-KDirector or officer change
Sep 10, 2026 - 8-KDirector or officer change
Aug 14, 2026 - 4Insider transaction report
Aug 12, 2026 - DEF 14AProxy statement
Aug 12, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026